A company with a device to detect early onset of age-related macular degeneration by measuring how patients adapt to darkness is raising $4 million in a series A financing round to bring the device to market. John Edwards, the CEO of Apeliotus Vision Science, said in an emailed response to questions that the company is […]
A company with a medical device to detect early onset of age-related macular degeneration, the leading cause of blindness in adults ages 50 or older, is raising $2 million in a series A preferred financing round to commercialize its diagnostic tool, which was approved by the U.S. Food and Drug Administration last year. Apeliotus Vision […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.